Abstract
Medulloblastoma (MB) occurs infrequently in adult patients and standard treatment is still controversial. We report our long-term, single-institution experience of adult MB and a review of the literature. We analysed adult patients with histologically proved MB treated by postoperative radiotherapy. Primary endpoints were local control (LC), disease-free survival (DFS), and overall survival (OS). Acute toxicity was reported according to CTC-NCI score vers. 3.0 and specific neuropsychological assessment analysis was performed to define late brain toxicity. From 1990–2008, 13 patients were treated by craniospinal (CSI, 12/13) or cranial irradiation (1/13, because of bad clinical conditions). Median follow up was 101 months (64–218). Complete radiological response was observed in 12/13 patients and a partial response in 1/13. Ten-year LC, OS, and DFS were 91, 76, and 84%, respectively. Two patients died because of local and spinal progression after 13 and 62 months. Acute G3 haematological toxicity (RTOG score) was observed for one patient only. The neuropsychological analysis did not reveal late toxicity related to brain radiotherapy. This experience confirms the efficacy and safety of radiotherapy in adult MB patients, resulting in very interesting 10-year LC and OS.
Similar content being viewed by others
References
Giordana MT, Schiffer P, Lanotte M, Girardi P, Chio A (1999) Epidemiology of adult medulloblastoma. Int J Cancer 80:689–692
Frost PJ, Laperriere NJ, Wong CS, Milosevic MF, Simpson WJ, Pintilie M (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32:951–957
Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 93:1351–1359
Mammarella IC, Toso C, Pazzaglia F, Cornoldi C (2005) BVS-Corsi: batteria per la valutazione della memoria visiva e spaziale. Erickson, Trento
Luria AR (1973) The working brain. Penguin Press, London
Rey A (1968) Reattivo della figura complessa. Organizzazioni Speciali, Firenze, pp 25–40
Krikorian R, Bartok J, Gay N (1994) Tower of London procedure: a standard method and developmental data. J Clin Exp Neuropsychol 16(6):840–850
Borkowsky JG, Benton AL, Spreen O (1967) Word fluency and brain damage. Neuropsychologia 5:135–140
Kertesz A, Nadkarni N, Davidson W, Thomas AW (2000) The frontal behavioral inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 6(4):460–468
Miceli G, Laudanna A, Burani C, Capasso R. (1994) Manuale per l’analisi dei deficit afasici. Universita` Cattolica del Sacro Cuore, Consiglio Nazionale delle Ricerche, Roma
American Association on Mental Retardation (AAMR) (2002) Mental retardation: definition, classification and system of support, 10th edn. Library of Congress, Washington DC
Association American Psychiatric (2000) DSM-IV-TR: diagnostic and statistical manual of mental disorders, 4th edn. Text revision. Masson, Milan, pp 31–291
Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 9:97–113
Gainotti G, Miceli G, Caltagirone C (1977) Constructional apraxia in left brain-damaged patients: A planning disorders? Cortex 13:109–118
Carlesimo GA, Caltagirone C, Gainotti G (1996) The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 36:378–384
Korshunov A, Remke M, Werft W, Benner A, Ryzhova M, Witt H, Sturm D, Wittmann A, Schöttler A, Felsberg J, Reifenberger G, Rutkowski S, Scheurlen W, Kulozik AE, von Deimling A, Lichter P, Pfister SM (2010) Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncol 28(18):3054–3060 Epub 2010 May 17
Padovani L, André N, Carrie C, Muracciole X (2009) Childhood and adult medulloblastoma: What difference? Cancer Radiother 13(6–7):530–535
Curran EK, Le GM, Sainani KL, Propp JM, Fisher PG (2009) Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. J Neurooncol 95(1):81–85
Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children’s cancer group study. J Clin Oncol 17:2127–2136
Warmuth-Metz M, Blashofer S, von Bueren AO, von Hoff K, Bison B, Pohl F, Kortmann RD, Pietsch T, Rutkowski S. (Nov 2010) Recurrence in childhood medulloblastoma. J Neurooncol. 2010 Nov 11
Brandes AA, Palmisano V, Monfardini S (1999) Medulloblastoma in adults: clinical characteristics and treatment. Cancer Treat Rev 25:3–12
Brandes AA, Paris MK (2004) Review of the prognostic factors in medulloblastoma of children and adults. Crit Rev Oncol Hematol 50:121–128
Lai R (2008) Survival of patients with adult medulloblastoma: a population-based study. Cancer 112(7):1568–1574
Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M (2007) Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110(9):2035–2041
Giordana MT, Cavalla P, Chiò A, Marino S, Soffietti R, Vigliani MC, Schiffer D (1995) Prognostic factors in adult medulloblastoma. A clinico-pathologic study. Tumori 81:338–346
Noel G, Merrer J (1997) Medulloblastoma in adults. Val-de-Grace hospital experience (1975–1994) and literature review. Cancer Radiother 1:60–67
Prados MD, Warnick RE, Wara WM, Larson DA, Lamborn K, Wilson CB (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32:1145–1152
Abacioglu U, Uzel O, Sengoz M, Turkan S, Ober A (2002) Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 54:855–860
Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, Chapman P, Loeffler JS (2000) Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 47:623–631
Kunschner LJ, Kuttesch J, Hess K, Yung WK (2001) Survival, recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neurooncology 3:167–173
Malheiros SM, Franco CM, Stávale JN, Santos AJ, Borges LR, Pelaez MP, Ferraz FA, Gabbai AA (2002) Medulloblastoma in adults: a series from Brazil. J Neurooncol 60:247–253
Carrie C, Lasset C, Alapetite C, Haie-Meder C, Hoffstetter S, Demaille MC, Kerr C, Wagner JP, Lagrange JL, Maire JP et al (1994) Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Cancer 74:2352–2360
Hartsell WF, Montag AG, Lydon J, Galinsky DL, Sarin P (1992) Treatment of medulloblastoma in adults. Am J Clin Oncol 15:207–211
Skolyszewski J, Glinski B (1989) Results of postoperative irradiation of medulloblastoma in adults. Int J Radiat Oncol Biol Phys 16:479–482
Boiardi A, Silvani A, Eoli M, Fariselli L, Zappacosta B, Salmaggi A (2000) Embryonal tumors in the adult population: implications in therapeutic planning. Neurol Sci 21:23–30
Hazuka MB, DeBiose DA, Henderson RH, Kinzie JJ (1992) Survival results in adult patients treated for medulloblastoma. Cancer 69:2143–2148
Coulbois S, Civit T, Grignon Y, Taillandier L, Girard F, Marchal C, Pinelli C, Auque J (2001) Adult medulloblastoma: review of 22 patients. Neurochirurgie 47:6–12
Haie C, Schlienger M, Constans JP, Meder JF, Reynaud A, Ghenim C (1985) Results of radiation treatment of medulloblastoma in adults. Int J Radiat Oncol Biol Phys 11:2051–2056
Le QT, Weil MD, Wara WM, Lamborn KR, Prados MD, Edwards MS, Gutin PH (1997) Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am 3:238–245
Greenberg HS, Chamberlain MC, Glantz MJ, Wang S (2001) Adult medulloblastoma: multiagent chemotherapy. Neurooncology 3:29–34
Ang C, Hauerstock D, Guiot MC, Kasymjanova G, Roberge D, Kavan P, Muanza T (2008) Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer 51(5):603–607
Carrie C, Lasset C, Blay JY, Négrier S, Bouffet E, Barbet N, Montbarbon X, Wagner JP, Lapras C, Deruty R et al (1993) Medulloblastoma in adults: survival and prognostic factors. Radiother Oncol 29(3):301–307
Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T (2009) Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg 111(3):478–487
Germanwala AV, Mai JC, Tomycz ND, Niranjan A, Flickinger JC, Kondziolka D, Lunsford LD (2008) Boost gamma knife surgery during multimodality management of adult medulloblastoma. J Neurosurg 108(2):204–209
Ertas G, Ucer AR, Altundag MB, Durmus S, Calikoglu T, Ozbagi K, Abanuz H, Altundag K, Demirkasimoglu A (2008) Medulloblastoma/primitive neuroectodermal tumor in adults: prognostic factors and treatment results: a single-center experience from Turkey. Med Oncol 25(1):69–72
Bloom HJ (1977) Medulloblastoma: prognosis and prospect. Int J Radiat Oncol Biol Phys 2:1031–1033
Roldán G, Brasher P, Vecil G et al (2008) Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996. Can J Neurol Sci 35:210–215
Guessous F, Li Y, Abounader R (2008) Signaling pathways in medulloblastoma. J Cell Physiol 217(3):577–583
Entz-Werle N, Carli ED, Ducassou S, Legrain M, Grill J, Dufour C (2008) Medulloblastoma: What is the role of molecular genetics? Expert Rev Anticancer Ther 8(7):1169–1181
Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A (2008) Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res 14(4):971–976
Bloom HJG, Bessell EM (1990) Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 18:763–772
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research, Treatment of Cancer Brain Tumor, Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996
Durando X, Thivat E, Gilliot O, Irthum B, Verrelle P, Vincent C, Bay JO (2007) Temozolomide treatment of an adult with a relapsing medulloblastoma. Cancer Invest 25(6):470–475
Mascarin M, Dall’Oglio S, Palazzi M, Sartor G, Marradi PL, Romano M, Maluta S (2010) A case of relapsed medulloblastoma treated with intensity-modulated radiotherapy and temozolomide. Tumori 96(2):327–331
Poelen J, Bernsen HJ, Prick MJ (2007) Metastatic medulloblastoma in an adult; treatment with temozolomide. Acta Neurol Belg 107(2):51–54
Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, Fort D, Friedman H, Harris MB, Tedeschi-Blok N, Mazewski C, Sato J, Reaman GH (2007) Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children’s Oncology Group. Cancer 110(7):1542–1550
Sterba J, Pavelka Z, Andre N, Ventruba J, Skotakova J, Bajciova V, Bronisova D, Dubska L, Valik D (2010) Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy. Pediatr Blood Cancer 54(4):616–617
Nicolson RI, Fawcett AJ (2011) Dislexia, dysgraphia, procedural learning and the cerebellum. Cortex 47(1):117–127
Valera EM, Spencer RM, Zeffiro TA, Makris N, Spencer TJ, Faraone SV, Biederman J, Seidman LJ (2010) Neural substrates of impaired sensorimotor timing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 68:359–367
Frange P, Alapetite C, Gaboriaud G, Bours D, Zucker JM, Zerah M, Brisse H, Chevignard M, Mosseri V, Bouffet E, Doz F (2009) From childhood to adulthood: long-term outcome of medulloblastoma patients The Institut Curie experience (1980–2000). J Neurooncol 95(2):271–279 Epub 2009 Jun 12
Haberer S, Assouline A, Mazeron JJ (2010) Normal tissue tolerance to external beam radiation therapy: brain and hypophysis. Cancer Radiother 14(4–5):263–268 French
Habrand JL, Drouet F (2010) Normal tissue tolerance to external beam radiation therapy: spinal cord. Cancer Radiother 14(4–5):269–276
Amelio D, Lorentini S, Schwarz M, Amichetti M (2010) Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. Radiother Oncol Radiother Oncol 97(3):361–369
Wagner D, Christiansen H, Wolff H, Vorwerk H (2009) Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol 93(3):593–596
Combs SE, Hartmann C, Nikoghosyan A, Jäkel O, Karger CP, Haberer T, von Deimling A, Münter MW, Huber PE, Debus J, Schulz-Ertner D (2010) Carbon ion radiation therapy for high-risk meningiomas. Radiother Oncol 95(1):54–59
Grosu AL, Weber WA (2010) PET for radiation treatment planning of brain tumours. Radiother Oncol 96(3):325–327
Leseur J, Carrie C, Le Prisé E, Bernier V, Beneyton V, Mahé MA, Supiot S (2009) Intensity-modulated radiotherapy for cancers in childhood. Cancer Radiother 13(6–7):536–542
Paulino AC, Mazloom A, Teh BS, South M, Okcu MF, Su J, Butler EB, Chintagumpala M (2011) Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer 117(3):635–641
Sharma DS, Gupta T, Jalali R, Master Z, Phurailatpam RD, Sarin R (2009) High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy. Br J Radiol 82(984):1000–1009
Fossati P, Ricardi U, Orecchia R (2009) Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev 35(1):79–96 Review
Jain N, Krull KR, Brouwers P, Chintagumpala MM, Woo SY (2008) Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma. Pediatr Blood Cancer 51(2):275–279
Seppälä J, Kulmala J, Lindholm P, Minn H (2010) A method to improve target dose homogeneity of craniospinal irradiation using dynamic split field IMRT. Radiother Oncol 96(2):209–215
Paulino AC, Lobo M, Teh BS, Okcu MF, South M, Butler EB, Su J, Chintagumpala M (2010) Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys 78(5):1445–1450
Muscal JA, Jones JY, Paulino AC, Bertuch AA, Su J, Woo SY, Mahoney DH Jr, Chintagumpala M (2009) Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys 73(1):214–221
Conflict of interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s11060-011-0708-0
Rights and permissions
About this article
Cite this article
Balducci, M., Chiesa, S., Chieffo, D. et al. The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature. J Neurooncol 106, 315–323 (2012). https://doi.org/10.1007/s11060-011-0665-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-011-0665-7